A Population-based Retrospective Cohort Study To Examine The Risk Of Psychiatric Side Effects Associated With Glucocorticoid Use In Adults In The United Kingdom: A Clinical Practice Research Datalink Study

Millions of patients prescribed common steroid drugs may develop psychiatric side effects that go unrecognised and untreated. This study uses anonymised UK health records to track whether glucocorticoids—used for conditions like asthma, arthritis, and allergies—trigger new diagnoses of depression, anxiety, mania, psychosis, delirium, or suicide attempts in adults. The problem is that doctors and patients often do not connect psychiatric symptoms to steroid use. Glucocorticoids are prescribed widely, but the true scale of these side effects remains unclear because existing evidence comes from small studies or clinical trials that excluded people with mental health histories. Without reliable population-level data, clinicians lack guidance on monitoring or preventing these harms. If this research succeeds, it could change prescribing practice. Doctors might screen patients more carefully before starting glucocorticoids, monitor for early warning signs, or choose alternative treatments for those at higher risk. The findings could also inform patient information leaflets and clinical guidelines, reducing preventable psychiatric emergencies. This is not fundamental science—it is a direct investigation of a real-world safety concern. The impact would be immediate: better-informed prescribing decisions and fewer patients experiencing severe, avoidable psychiatric side effects from a common medication.